Kohei Koga Selected Research

Kohei Koga Research Topics

Disease

7	Chronic Pain 12/2019 - 12/2010
7	Pain (Aches) 12/2019 - 12/2010
5	Hypersensitivity (Allergy) 02/2020 - 11/2004
4	Neuralgia (Stump Neuralgia) 12/2019 - 01/2011
4	Inflammation (Inflammations) 12/2019 - 12/2005
3	Peripheral Nerve Injuries 10/2014 - 12/2010
3	Hyperalgesia 05/2007 - 11/2004
2	Pruritus (Itching) 09/2013 - 06/2011
1	Tobacco Use Disorder (Nicotine Dependence) 12/2021
1	Synucleinopathies 08/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 08/2020
1	Seizures (Absence Seizure) 08/2020
1	Neuroinflammatory Diseases 01/2019
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2018
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2014

Drug/Important Bio-Agent (IBA)

4	Muscarinic M1 ReceptorIBA 02/2020 - 11/2004
4	Freund's AdjuvantIBA 01/2019 - 12/2005
4	Analgesics (Analgesic Drugs)IBA 01/2018 - 01/2011
3	(4- (m- Chlorophenylcarbamoyloxy)- 2- butynyl)trimethylammonium ChlorideIBA 02/2020 - 11/2004
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2010
3	5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanolIBA 10/2014 - 01/2011
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2020 - 05/2013
2	Glutamic Acid (Glutamate)FDA Link 12/2019 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2014 - 01/2011
2	Gabapentin (Neurontin)FDA LinkGeneric 10/2014 - 06/2014
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 08/2014 - 01/2011
2	Kainic Acid (Kainate)IBA 09/2013 - 06/2011
2	Protein Kinase CIBA 12/2010 - 05/2007
2	Streptozocin (Streptozotocin)FDA Link 05/2007 - 11/2004
1	Nicotine FDA Link 12/2021
1	LigandsIBA 08/2020
1	Fatty Acid Binding Protein 3IBA 08/2020
1	Diazepam (Valium)FDA LinkGeneric 08/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 08/2020
1	Pentylenetetrazole (Metrazol)IBA 08/2020
1	Dizocilpine Maleate (Dizocilpine)IBA 02/2020
1	BicucullineIBA 02/2020
1	GABA Receptors (GABA Receptor)IBA 02/2020
1	TRPV1 receptorIBA 12/2019
1	Capsaicin (Zostrix)FDA Link 12/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2019
1	Baclofen FDA LinkGeneric 06/2018
1	Fragile X Mental Retardation ProteinIBA 01/2018
1	BenzodiazepinesIBA 01/2017
1	gamma-Aminobutyric Acid (GABA)IBA 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016
1	AMPA Receptors (AMPA Receptor)IBA 10/2014
1	ColforsinIBA 08/2014
1	adenylyl cyclase 1IBA 06/2014
1	ZymosanIBA 06/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2013
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 06/2011
1	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA 06/2011
1	Peptides (Polypeptides)IBA 12/2010
1	PlasticsIBA 12/2010
1	calphostin CIBA 05/2007
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2007
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 05/2007
1	Nerve Growth Factor (NGF)IBA 12/2005
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2005
1	Lidocaine (Xylocaine)FDA LinkGeneric 12/2005
1	Clonidine (ST 155)FDA LinkGeneric 11/2004

Therapy/Procedure

3	Ligation 02/2020 - 06/2018
1	Intraperitoneal Injections 06/2014
1	Spinal Injections 05/2007